Association of Multiple Developmental Defects and Embryonic Lethality with Loss of Microsomal NADPH-Cytochrome P450 Oxidoreductase
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
The microsomal flavoprotein NADPH-cytochrome P450 oxidoreductase (CYPOR) is believed to function as the primary, if not sole, electron donor for the microsomal cytochrome P450 mixed-function oxidase system. Development of the mammalian embryo is dependent upon temporally and spatially regulated expression of signaling factors, many of which are synthesized and/or degraded via the cytochromes P450 and other pathways involving NADPH-cytochrome P450 oxidoreductase as the electron donor. Expression of CYPOR as early as the two-cell stage of embryonic development (The Institute for Genomic Research Mouse Gene Index, version 5.0, www.tigr.org/tdb/mgi) suggests that CYPOR is essential for normal cellular functions and/or early embryogenesis. Targeted deletion of the translation start site and membrane-binding domain of CYPOR abolished microsomal CYPOR expression and led to production of a truncated, 66-kDa protein localized to the cytoplasm. Although early embryogenesis was not affected, a variety of embryonic defects was observable by day 10.5 of gestation, leading to lethality by day 13.5. Furthermore, a deficiency of heterozygotes was observed in 2-week-old mice as well as late gestational age embryos, suggesting that loss of one CYPOR allele produced some embryonic lethality. CYPOR -/- embryos displayed a marked friability, consistent with defects in cell adhesion. Ninety percent of CYPOR -/- embryos isolated at days 10.5 or 11.5 of gestation could be classified as either Type I, characterized by grossly normal somite formation but having neural tube, cardiac, eye, and limb abnormalities, or Type II, characterized by a generalized retardation of development after approximately day 8.5 of gestation. No CYPOR -/- embryos were observed after day 13.5 of gestation. These studies demonstrate that loss of microsomal CYPOR does not block early embryonic development but is essential for progression past mid-gestation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“No PORD patient carrying null mutations on both alleles has been described so far, suggesting incompatibility of such genotype with postnatal life, similar to the observation of early fetal death in the murine por deletion model (19, 20).”
From Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency (2012) · cites this paper as [19]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Type I embryos appeared normal until embryonic day 10.5 (E10.5) and had grossly normal somite formation, but they had cardiac, neural tube, eye, and limb defects and died by E13.5.”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [310]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Type II embryos had generally retarded development by E8.5 and died shortly thereafter (310).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [310]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Consistent with this, genetically engineered POR-knockout mice die during fetal development (310,311).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [310]
The cited source says what the claim attributes to it.
In the citing paper
“Homozygous knockout mice had either of two phenotypes.”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [310]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE HEME OXYGENASE SYSTEM:A Regulator of Second Messenger Gases
Maines, M. D. (1997) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.37.1.517 · Cited by 2,505
Derivation of completely cell culture-derived mice from early-passage embryonic stem cells.
Nagy, A., Rossant, J., Nagy, R., Abramow-Newerly, W., & Roder, J. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8424 · Cited by 2,329
Current Protocols in Molecular Biology
Teplitz, R. (1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03420090114049 · Cited by 1,803
Cytochrome P450: Structure, mechanism, and biochemistry
Pryor, W. A. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(96)83807-x · Cited by 1,598 · cited 1×
“NADPH-cytochrome P450 oxidoreductase (CYPOR) is an essential component of the microsomal P450 mixed-function oxidase system (1), mediating electron transfer from NADPH to the cytochromes P450, and a variety of other acceptors, including heme oxygenase (2), fatty acid elongase (3), cytochrome b5 (4) and squalene monoxy…”
BackgroundCholesterol Modification of Hedgehog Signaling Proteins in Animal Development
Porter, J. A., Young, K. E., & Beachy, P. A. (1996) · Science · doi:10.1126/science.274.5285.255 · Cited by 1,360
Burke, M. D., Thompson, S., Elcombe, C. R., Halpert, J., Haaparanta, T., & Mayer, R. T. (1985) · Biochemical Pharmacology · doi:10.1016/0006-2952(85)90355-7 · Cited by 1,275
Functional genomic analysis of cell division in C. elegans using RNAi of genes on chromosome III
Gönczy, P., Echeverri, C., Oegema, K., Coulson, A., Jones, S. J. M., Copley, R. R., Duperon, J., Oegema, J., Brehm, M., Cassin, E., et al. (2000) · Nature · doi:10.1038/35042526 · Cited by 867
Retinoids in Embryonal Development
Ross, S. A., McCaffery, P. J., Drager, U. C., & De Luca, L. M. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.3.1021 · Cited by 866
Abu-Abed, S., Dollé, P., Metzger, D., Beckett, B., Chambon, P., & Petkovich, M. (2001) · Genes & Development · doi:10.1101/gad.855001 · Cited by 578
Sakai, Y., Meno, C., Fujii, H., Nishino, J., Shiratori, H., Saijoh, Y., Rossant, J., & Hamada, H. (2001) · Genes & Development · doi:10.1101/gad.851501 · Cited by 456
Research works printed but not linked: 1
- Pikuleva, 1999, Mol. Aspects Med., 20, 33
Cited by
Zanger, U. M., & Schwab, M. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.12.007 · Cited by 4,169
“Complete deletion of the por gene in mouse is embryonically lethal most likely due to deficient adrenocortical steroidogenesis (Shen et al., 2002; Otto et al., 2003).”
BackgroundThe Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Yan, B., Ai, Y., Sun, Q., Ma, Y., Cao, Y., Wang, J., Zhang, Z., & Wang, X. (2021) · Molecular Cell · doi:10.1016/j.molcel.2020.11.024 · Cited by 617
Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome
Flück, C. E., Tajima, T., Pandey, A. V., Arlt, W., Okuhara, K., Verge, C. F., Jabs, E. W., Mendonça, B. B., Fujieda, K., & Miller, W. L. (2004) · Nature Genetics · doi:10.1038/ng1300 · Cited by 509
Malformation syndromes caused by disorders of cholesterol synthesis
Porter, F. D., & Herman, G. E. (2011) · Journal of Lipid Research · doi:10.1194/jlr.r009548 · Cited by 473
Goldstone, J. V., McArthur, A. G., Kubota, A., Zanette, J., Parente, T., Jönsson, M. E., Nelson, D. R., & Stegeman, J. J. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-643 · Cited by 425
Steroidogenesis in the Fetal Testis and Its Susceptibility to Disruption by Exogenous Compounds
Scott, H. M., Mason, J. I., & Sharpe, R. M. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0016 · Cited by 350
Arlt, W., Walker, E. A., Draper, N., Ivison, H. E., Ride, J. P., Hammer, F., Chalder, S. M., Borucka-Mankiewicz, M., Hauffa, B. P., Malunowicz, E. M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16503-3 · Cited by 345
Huang, N., Pandey, A. V., Agrawal, V., Reardon, W., Lapunzina, P. D., Mowat, D., Jabs, E. W., Vliet, G. V., Sack, J., Flück, C. E., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/429417 · Cited by 336
“2003), whereas the global Por-knockout mouse is embryonic lethal (Shen et al. 2002; Otto et al. 2003).”
BackgroundMinireview: Regulation of Steroidogenesis by Electron Transfer
Miller, W. L. (2005) · Endocrinology · doi:10.1210/en.2005-0096 · Cited by 324
Harris, M. J., & Juriloff, D. M. (2007) · Birth Defects Research Part A: Clinical and Molecular Teratology · doi:10.1002/bdra.20333 · Cited by 314
Iyanagi, T. (2007) · International Review of Cytology · doi:10.1016/s0074-7696(06)60002-8 · Cited by 290
NADPH P450 oxidoreductase: Structure, function, and pathology of diseases
Pandey, A. V., & Flück, C. E. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.010 · Cited by 279
Henderson, C. J., Otto, D. M. E., Carrie, D., Magnuson, M. A., McLaren, A. W., Rosewell, I., & Wolf, C. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212087200 · Cited by 258
Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues
Choudhary, D., Jansson, I., Schenkman, J. B., Sarfarazi, M., & Stoilov, I. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(03)00174-7 · Cited by 252
Pharmacogenomics of Cytochrome P450 3A4: Recent Progress Toward the “Missing Heritability” Problem
Klein, K., & Zanger, U. M. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00012 · Cited by 220
“Complete deletion of the por gene in mouse is embryonically lethal most likely due to deficient adrenocortical steroidogenesis (Shen et al., 2002; Otto et al., 2003).”
BackgroundLiver-specific Deletion of the NADPH-Cytochrome P450 Reductase Gene
Gu, J., Weng, Y., Zhang, Q.-Y., Cui, H., Behr, M., Wu, L., Yang, W., Zhang, L., & Ding, X. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303125200 · Cited by 214
Huang, N., Agrawal, V., Giacomini, K. M., & Miller, W. L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711621105 · Cited by 198
“Finding severe POR mutations in human patients was unexpected, because POR knockout mice die during embryonic development (9, 10).”
BackgroundLorbek, G., Lewinska, M., & Rozman, D. (2012) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08432.x · Cited by 196
The roles of cytochrome b5 in cytochrome P450 reactions
Porter, T. D. (2002) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.10052 · Cited by 193
“Although cytochrome P450 reductase is evidently essential for mammalian development and viability [16], P450 reductase is dispensable in yeast, as demonstrated by the survival of a Saccharomyces cerevisiae strain with a disrupted P450 reductase gene [17].”
BackgroundOtto, D. M. E., Henderson, C. J., Carrie, D., Davey, M., Gundersen, T. E., Blomhoff, R., Adams, R. H., Tickle, C., & Wolf, C. R. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.17.6103-6116.2003 · Cited by 189
“(44) and our data indicate that electron transport via CPR is essential to maintain adequate cytochrome P450 functioning in the early stages of mammalian development.”
BackgroundGenotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency
Krone, N., Reisch, N., Idkowiak, J., Dhir, V., Ivison, H. E., Hughes, B. A., Rose, I. T., O'Neil, D. M., Vijzelaar, R., Smith, M. J., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0640 · Cited by 163
Fukami, M., Horikawa, R., Nagai, T., Tanaka, T., Naiki, Y., Sato, N., Okuyama, T., Nakai, H., Soneda, S., Tachibana, K., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0810 · Cited by 155
“In this context, the previous studies have indicated that all the nine patients have at least one missense mutations with residual POR activities (6, 14), explaining why POR mutation-positive patients are compatible with life, whereas Por knockout mice are embryonically lethal (29).”
BackgroundNADPH–Cytochrome P450 Oxidoreductase: Roles in Physiology, Pharmacology, and Toxicology
Riddick, D. S., Ding, X., Wolf, C. R., Porter, T. D., Pandey, A. V., Zhang, Q., Gu, J., Finn, R. D., Ronseaux, S., McLaughlin, L. A., et al. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.048991 · Cited by 164
“Germ-line deletion of Por in mice results in multiple developmental defects and embryonic lethality (Shen et al., 2002; Otto et al., 2003), confirming the importance of POR in normal physiology.”
BackgroundGilep, A. A., Sushko, T. A., & Usanov, S. A. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2010.06.021 · Cited by 145
Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase
Pandey, A. V., Kempná, P., Hofer, G., Mullis, P. E., & Flück, C. E. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0245 · Cited by 132
Congenital adrenal hyperplasia and P450 oxidoreductase deficiency
Krone, N., Dhir, V., Ivison, H. E., & Arlt, W. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02740.x · Cited by 131
Gomes, A. M., Winter, S., Klein, K., Turpeinen, M., Schaeffeler, E., Schwab, M., & Zanger, U. M. (2009) · Pharmacogenomics · doi:10.2217/pgs.09.7 · Cited by 125
Redox Control in Mammalian Embryo Development
Ufer, C., Wang, C. C., Borchert, A., Heydeck, D., & Kühn, H. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.3044 · Cited by 131
“When the CPR membrane binding domain, which is thought to be vital for CPR function, was deleted, a less severe phenotype was observed affecting mostly neural tube and heart development (357).”
Agrawal, V., Huang, N., & Miller, W. L. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32830054ac · Cited by 117
NADPH–cytochrome P450 oxidoreductase: Prototypic member of the diflavin reductase family
Iyanagi, T., Xia, C., & Kim, J.-J. P. (2012) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2012.09.002 · Cited by 117
Genetic and clinical features of P450 oxidoreductase deficiency
Scott, R. R., & Miller, W. L. (2008) · Hormone Research in Paediatrics · doi:10.1159/000114857 · Cited by 115
Oneda, B., Crettol, S., Sirot, E. J., Bochud, M., Ansermot, N., & Eap, C. B. (2009) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32833225e7 · Cited by 115
Structural basis for human NADPH-cytochrome P450 oxidoreductase deficiency
Xia, C., Panda, S. P., Marohnic, C. C., Martásek, P., Masters, B. S., & Kim, J.-J. P. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106632108 · Cited by 115
“Retardation of somite and limb bud formation, observed previously in embryonically lethal CYPOR knockout mice (10, 11), supports this hypothesis.”
InfluentialA Model of the Membrane-bound Cytochrome b5-Cytochrome P450 Complex from NMR and Mutagenesis Data
Ahuja, S., Jahr, N., Im, S., Vivekanandan, S., Popovych, N., Clair, S. V. L., Huang, R., Soong, R., Xu, J., Yamamoto, K., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.448225 · Cited by 117
“They are found in all tissues of the body and are responsible for influencing a dazzling array of biochemical and physiological processes, including embryonic development, blood coagulation, and the metabolism of carcinogens, environmental toxins, over 50% of drugs in use, vitamin D, and other exogenous and endogenous…”
BackgroundStructural diversity of cytochrome P450 enzyme system
Omura, T. (2010) · The Journal of Biochemistry · doi:10.1093/jb/mvq001 · Cited by 112
Adachi, M., Tachibana, K., Asakura, Y., Yamamoto, T., Hanaki, K., & Oka, A. (2004) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30169 · Cited by 110
“It is noteworthy that the POR / mouse die prenatally [Shen et al., 2002], and POR is thought to be essential for progression past midgestation.”
BackgroundRoberts, C., Ivins, S. M., Cook, A. C., Baldini, A., & Scambler, P. J. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl416 · Cited by 112
“Interestingly, homozygous null mutants for cytochrome P450 reductase, the essential electron donor for Cyp26s, have a severe embryonic lethal phenotype which includes loss of the pa as well as more extreme phenotypes such as defective vasculogenesis and somitogenesis, heart oedema and anterior and caudal truncation (9…”
BackgroundAgrawal, V., Choi, J. H., Giacomini, K. M., & Miller, W. L. (2010) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32833e0cb5 · Cited by 104
Guengerich, F. P., & Cheng, Q. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003525 · Cited by 103
“In addition, deletion of NADPH-P450 reductase is lethal to mouse embryos (Shen et al., 2002), although the exact reason is not clear [attenuation of the reductase in selected organs in mice has a relatively modest effect (Gu et al.”
BackgroundZhu, F., Sams, S., Moural, T. W., Haynes, K. F., Potter, M. F., & Palli, S. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031037 · Cited by 115
“multiple developmental defects and embryonic lethality in mouse [47,48] and increase the permethrin susceptibility in An gambiae”
Keber, R., Motaln, H., Wagner, K. D., Debeljak, N., Rassoulzadegan, M., Ačimovič, J., Rozman, D., & Horvat, S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.253245 · Cited by 102
Johnson, B. P., Walisser, J. A., Liu, Y., Shen, A. L., McDearmon, E. L., Moran, S. M., McIntosh, B. E., Vollrath, A. L., Schook, A. C., Takahashi, J. S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421708111 · Cited by 106
Self-citationHart, S. N., Wang, S., Nakamoto, K., Wesselman, C., Li, Y., & Zhong, X.-B. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3282f2f121 · Cited by 98
Pharmacogenomics of human P450 oxidoreductase
Pandey, A. V., & Sproll, P. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00103 · Cited by 92
“POR knockout mice are embryonic lethal (Shen et al., 2002; Otto et al., 2003).”
BackgroundInfluentialWeng, Y., Fang, C., Turesky, R. J., Behr, M. J., Kaminsky, L. S., & Ding, X. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1006 · Cited by 101
“Germ-line deletion of Cpr is embryonically lethal in mice (6, 7).”
BackgroundConsequences of POR mutations and polymorphisms
Miller, W. L., Agrawal, V., Sandee, D., Tee, M. K., Huang, N., Choi, J. H., Morrissey, K., & Giacomini, K. M. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.10.022 · Cited by 88
“POR Deficiency Syndromes The essential role of POR in so many reactions predicts that POR mutations should yield a very severe phenotype, and POR-knockout mice die during fetal development (Otto et al., 2003; Shen et al., 2002).”
BackgroundInfluentialReed, L., Arlt, V. M., & Phillips, D. H. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy058 · Cited by 100
“Systemic knockout of POR in mice utilizing the Cre/loxP system results in embryonic lethality due to the requirement for P450 expression during development (37).”
MethodClinical, genetic and enzymatic characterization of P450 oxidoreductase deficiency in four patients
Sahakitrungruang, T., Huang, N., Tee, M. K., Agrawal, V., Russell, W. E., Crock, P., Murphy, N., Migeon, C. J., & Miller, W. L. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1460 · Cited by 82
Scott, R. R., Gomes, L. G., Huang, N., Van Vliet, G., & Miller, W. L. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2345 · Cited by 79
Sterol 14α-demethylase, an abundant and essential mixed-function oxidase
Waterman, M. R., & Lepesheva, G. I. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.118 · Cited by 79
Sugamori, K. S., Wong, S. Y., Gaedigk, A., Yu, V. L., Abramovici, H., Rozmahel, R. F., & Grant, D. M. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.1.170 · Cited by 76
“…been associated with any of the cytochrome P450 knockouts (Cyp1a1, Cyp1a2, Cyp1b1, Cyp2e1) or the microsomal epoxide hydrolase knockout (Gonzalez and Kimura, 2003), although knockout of the microsomal NADPH-cytochrome P450 oxidoreductase gene did result in embryonic lethality (Shen et al., 2002).”
BackgroundMiller, W. L. (2004) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2004.07.005 · Cited by 82
Effects of genetic variants of human P450 oxidoreductase on catalysis by CYP2D6 in vitro
Sandee, D., Morrissey, K., Agrawal, V., Tam, H. K., Kramer, M. A., Tracy, T. S., Giacomini, K. M., & Miller, W. L. (2010) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32833f4f9b · Cited by 74
Ribes, V., Otto, D. M. E., Dickmann, L., Schmidt, K., Schuhbaur, B., Henderson, C., Blomhoff, R., Wolf, C. R., Tickle, C., & Dollé, P. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2006.10.032 · Cited by 73
“Functional inactivation of the Por gene in mice leads to severe developmental defects and death at embryonic day (E) 9.5 (Otto et al., 2003; Shen et al., 2002).”
BackgroundInfluentialElectron Transfer Partners of Cytochrome P450
Paine, M. J. I., Scrutton, N. S., Munro, A. W., Gutiérrez, A., Roberts, G. C. K., & Wolf, C. R. (2007) · Springer eBooks · doi:10.1007/0-387-27447-2_4 · Cited by 79
Wu, L., Gu, J., Cui, H., Zhang, Q.-Y., Behr, M. J., Fang, C., Weng, Y., Kluetzman, K., Swiatek, P. J., Yang, W., et al. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.073353 · Cited by 71
“The Cprlow/low mice also differ from the germline Cpr-null mice, which are embryonic lethal (Shen et al., 2002; Otto et al., 2003), in that their CPR expression is globally reduced, but not abolished.”
BackgroundResultInfluentialConditional knockout of the mouse NADPH‐cytochrome p450 reductase gene
Wu, L., Gu, J., Weng, Y., Kluetzman, K., Swiatek, P., Behr, M., Zhang, Q., Zhuo, X., Xie, Q., & Ding, X. (2003) · genesis · doi:10.1002/gene.10214 · Cited by 68
“A critical role of microsomal CYP enzymes in embryonic development was recently demonstrated in a knockout mouse model with germline deletion of the Cpr gene (Shen et al., 2002).”
BackgroundHorvat, S., Mcwhir, J., & Rozman, D. (2011) · Drug Metabolism Reviews · doi:10.3109/03602532.2010.540580 · Cited by 67
“The first report of the Por knockout (Shen et al., 2002) shows a variety of embryonic defects from day 10.5 of gestation.”
BackgroundInfluentialWeng, Y., Dirusso, C., Reilly, A. A., Black, P. N., & Ding, X. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504447200 · Cited by 73
P450 oxidoreductase: genetic polymorphisms and implications for drug metabolism and toxicity
Hart, S. N., & Zhong, X.-B. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.4.439 · Cited by 70
“vascular defects [45, 46 ] . These irregularities are thought to be caused by a number of factors, including elevated retinoic acid levels due to the loss of Cyp26 activity [45] , which normally metabolizes all-trans retinoic acids into hydroxyretinoic acids and 4-oxoretinoic acids for elimination.”
BackgroundElectron Transfer Partners of Cytochrome P450
Waskell, L. A., & Kim, J. P. (2015) · Springer eBooks · doi:10.1007/978-3-319-12108-6_2 · Cited by 87
“Neural tube, cardiac, eye, limb, and vascular defects are seen in homozygous null embryos, as well as a failure of development, which have been ascribed to defects in cholesterol and retinoid metabolism [101, 102].”
BackgroundFlück, C. E., Mullis, P. E., & Pandey, A. V. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.09.035 · Cited by 59
“supported by embryonic lethality of POR knocks-out mice [7].”
BackgroundSchmidt, K., Hughes, C., Chudek, J. A., Goodyear, S. R., Aspden, R. M., Talbot, R., Gundersen, T. E., Blomhoff, R., Henderson, C., Wolf, C. R., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01638-08 · Cited by 61
Pinto, J. T., & Cooper, A. J. L. (2014) · Advances in Nutrition · doi:10.3945/an.113.005181 · Cited by 67
Structure and function of NADPH-cytochrome P450 reductase and nitric oxide synthase reductase domain
Iyanagi, T. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.043 · Cited by 71
Marohnic, C. C., Panda, S. P., Martásek, P., & Masters, B. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607095200 · Cited by 57
P450 oxidoreductase deficiency: a new form of congenital adrenal hyperplasia
Flück, C. E., & Miller, W. L. (2006) · Current Opinion in Pediatrics · doi:10.1097/01.mop.0000236395.71956.5c · Cited by 57
Flück, C. E., Nicolo, C., & Pandey, A. V. (2007) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2007.00520.x · Cited by 55
Genetic variation in human P450 oxidoreductase
Miller, W. L., Huang, N., Agrawal, V., & Giacomini, K. M. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.09.017 · Cited by 54
Disorders of Androgen Synthesis – from Cholesterol to Dehydroepiandrosterone
Miller, W. L. (2005) · Medical Principles and Practice · doi:10.1159/000086185 · Cited by 61
“but this seemed unlikely as POR knockout mice do not survive past the middle of fetal development [”
BackgroundThe Adrenal Cortex and its Disorders
Miller, W. L. (2009) · Brook's Clinical Pediatric Endocrinology · doi:10.1002/9781444316728.ch13 · Cited by 50
Clinical and Biochemical Consequences of P450 Oxidoreductase Deficiency
Flück, C. E., & Pandey, A. V. (2011) · Endocrine Development · doi:10.1159/000321221 · Cited by 52
Laursen, T., Singha, A., Rantzau, N., Tutkus, M., Borch, J., Hedegård, P., Stamou, D. G., Møller, B. L., & Hatzakis, N. S. (2013) · ACS Chemical Biology · doi:10.1021/cb400708v · Cited by 53
Elmore, C. L., & Porter, T. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m210173200 · Cited by 53
Chen, X., Pan, L. Q., Naranmandura, H., Zeng, S., & Chen, S. Q. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038495 · Cited by 53
“Recently, it has been reported that the genetic polymorphisms of POR had definitely affected endocrinology, pharmacology and as well as the developmental biology [17,18].”
BackgroundCytochrome P450 17A1 Interactions with the FMN Domain of Its Reductase as Characterized by NMR
Estrada, D. F., Laurence, J. S., & Scott, E. E. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.677294 · Cited by 47
“These reactions are all critically dependent on a single multidomain NADPH-cytochrome P450 oxidoreductase (CPR)(3) enzyme (1).”
BackgroundBozcaarmutlu, A., & Arınç, E. (2006) · Toxicology in Vitro · doi:10.1016/j.tiv.2006.10.002 · Cited by 44
“Knocking out the cytochrome P450 reductase gene in mice leads to embryonic lethality, and missense mutations cause disordered steroidogenesis, ambiguous genitalia, and Antley-Bixler syndrome (Shen et al., 2002; Otto et al., 2003; Huang et al., 2005; Iyanagi, 2005).”
BackgroundA novel humanized mouse lacking murine P450 oxidoreductase for studying human drug metabolism
Barzi, M., Pankowicz, F. P., Zorman, B., Liu, X., Legras, X., Yang, D., Borowiak, M., Bissig-Choisat, B., Sumazin, P., Li, F., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00049-x · Cited by 42
A Minimal Functional Complex of Cytochrome P450 and FBD of Cytochrome P450 Reductase in Nanodiscs
Prade, E., Mahajan, M. K., Im, S., Zhang, M., Gentry, K. A., Anantharamaiah, G. M., Waskell, L. A., & Ramamoorthy, A. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201802210 · Cited by 49
Elens, L., Nieuweboer, A. J. M., Clarke, S. J., Charles, K. A., de Graan, A. M., Haufroid, V., van Gelder, T., Mathijssen, R. H. J., & van Schaik, R. H. N. (2013) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32835dc113 · Cited by 46
Roberts, C. (2020) · Journal of Developmental Biology · doi:10.3390/jdb8010006 · Cited by 51
Huang, R., Yamamoto, K., Zhang, M., Popovych, N., Hung, I., Im, S., Gan, Z., Waskell, L. A., & Ramamoorthy, A. (2014) · Biophysical Journal · doi:10.1016/j.bpj.2014.03.051 · Cited by 42
Flück, C. E., Mallet, D., Hofer, G., Samara‐Boustani, D., Léger, J., Polak, M., Morel, Y., & Pandey, A. V. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.08.001 · Cited by 43
“2) [10], therefore, chances of mutations in POR gene and a malfunctioning POR protein was suggested by Miller [11] but deemed unlikely due to requirement of POR in multiple biochemical processes [11]; embryonic lethality of the POR knock-out mice later seemed to support that theory [12].”
BackgroundPandey, A. V., Flück, C. E., Huang, N., Tajima, T., Fujieda, K., & Miller, W. L. (2004) · Endocrine Research · doi:10.1081/erc-200044134 · Cited by 39
Bueters, R., Bael, A., Gasthuys, E., Chen, C. L., Schreuder, M. F., & Frazier, K. S. (2020) · Drug Metabolism and Disposition · doi:10.1124/dmd.119.089755 · Cited by 40
“The importance of this enzyme is apparent because of observed embryonic lethality in knockout mice around day 8 to 9 (Shen et al., 2002; Henderson et al., 2003).”
BackgroundDrug-metabolizing enzyme, transporter, and nuclear receptor genetically modified mouse models
Jiang, X.-L., Gonzalez, F. J., & Yu, A. (2010) · Drug Metabolism Reviews · doi:10.3109/03602532.2010.512294 · Cited by 41
“…CYP3A4 Knockout Humanized Docetaxel metabolism and pharmacokinetics (van Herwaarden et al., 2007) Cpr Knockout Drug metabolism and toxicity (Shen et al., 2002; Otto et al., 2003; Gu et al., 2003; Henderson et al., 2003a; Wu et al., 2003) Gstp Knockout DMBA carcinogenesis; acetaminophen…”
BackgroundRecruitment of governing elements for electron transfer in the nitric oxide synthase family
Jáchymová, M., Martasek, P., Panda, S. P., Roman, L. J., Panda, M., Shea, T. M., Ishimura, Y., Kim, J. J., & Masters, B. S. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506522102 · Cited by 42
Multigene Predictors of Tacrolimus Exposure in Kidney Transplant Recipients
Pulk, R., Schladt, D. P., Oetting, W. S., Guan, W., Israni, A. K., Matas, A. J., Remmel, R. P., Jacobson, P. A., & for the DeKAF Investigators (2015) · Pharmacogenomics · doi:10.2217/pgs.15.42 · Cited by 39
Adrenal androgens, adrenarche, and zona reticularis: A human affair?
Dumontet, T., & Martinez, A. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111239 · Cited by 44
Lin, Y., Yao, Y., Liu, S., Wang, L., Moorthy, B., Xiong, D., Cheng, T., Ding, X., & Gu, J. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.05.005 · Cited by 35
“Germline disruption of the mouse Cpr gene led to a spectrum of embryonic defects and mid-gestational lethality, indicating that CPR is essential for early embryonic development (Shen et al, 2002).”
Collier, A. C. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(03)00274-6 · Cited by 36
McCammon, K. M., Panda, S. P., Xia, C., Kim, J.-J. P., Moutinho, D., Kranendonk, M., Auchus, R. J., Lafer, E. M., Ghosh, D., Martasek, P., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.716019 · Cited by 33
Cytochrome P450 Oxidoreductase Deficiency
Idkowiak, J., Cragun, D. L., Hopkin, R. J., & Arlt, W. (2009) · University of Washington, Seattle eBooks · Cited by 33
Elens, L., Sombogaard, F., Hesselink, D. A., van Schaik, R. H. N., & van Gelder, T. (2013) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000001 · Cited by 37
ATR3 encodes a diflavin reductase essential for Arabidopsis embryo development
Varadarajan, J., Guilleminot, J., Saint‐Jore‐Dupas, C., Piégu, B., Chabouté, M., Gomord, V., Coolbaugh, R. C., Devic, M., & Delorme‐Hinoux, V. (2010) · New Phytologist · doi:10.1111/j.1469-8137.2010.03254.x · Cited by 38
Electron Transfer Pathways in Cholesterol Synthesis
Porter, T. D. (2015) · Lipids · doi:10.1007/s11745-015-4065-1 · Cited by 34
“Germ-line deletion of the cytochrome P450 reductase gene is lethal during embryogenesis in mice [14, 15], but tissue and organ-specific deletions are viable and have been used to study the role of cytochrome P450 reductase in various tissues, primarily with regard to drug metabolism by the cytochrome P450 enzymes.”
BackgroundDobrinas, M., Cornuz, J., Pedrido, L., & Eap, C. B. (2012) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32834e9e1a · Cited by 32
Cytochromes P450—A Family of Proteins and Scientists–Understanding their Relationships
Masters, B. S. S., & Marohnic, C. C. (2006) · Drug Metabolism Reviews · doi:10.1080/03602530600570065 · Cited by 35
“As opposed to the knockout from Kasper’s group (Shen et al., 2002), this null mouse retained no residual cytosolic CYPOR, and therefore resulted in a more severe phenotype and embryonic death at E10.”
MethodResultInfluentialP450 oxidoreductase deficiency and Antley–Bixler syndrome
Arlt, W. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9056-y · Cited by 36
“Of note, the complete deletion of the murine Por gene results in a non-viable phenotype [36, 37].”
Background
Metadata
- Authors
- Shen, A. L., O'Leary, K. A., & Kasper, C. B.
- Affiliations
- University of Wisconsin–Madison (US)
- Corresponding author
- Kasper, Charles B.
- ORCID
- Shen, Anna L.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-02
- Volume
- 277
- Issue
- 8
- Pages
- 6536-6541
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2019819564
- Semantic Scholar
- 023cbff56807eedc0abd9435cefe2166ffaa2b1f
- Cited by
- 225
- References
- 34
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 3 · 2023: 6 · 2022: 6 · 2021: 16 · 2020: 8 · 2019: 4 · 2018: 7 · 2017: 4 · 2016: 5 · 2015: 10 · 2014: 13 · 2013: 16 · 2012: 15
- FWCI
- 7.12
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6836 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- University of Wisconsin-Madison
- University of Utah
- National Institutes of Health (5p30ca007175-36, 5p30es009090-04, CA22484)
- National Cancer Institute (CA-07175, CA 22484, P01CA022484)
- National Institute of Environmental Health Sciences (P30 ES09090-04)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
- Keywords
- NADPH-cytochrome P450 reductase, embryonic lethality, developmental defects, mixed function oxidase, truncated protein, cell adhesion, neural tube defects, cardiac defects, eye defects, limb malformations, somitogenesis, mouse embryo, heterozygote deficiency
- MeSH terms
- Abnormalities, Multiple, Animals, Crosses, Genetic, Fetal Death, Gestational Age, Heart Defects, Congenital, NADPH-Ferrihemoprotein Reductase, Neural Tube Defects, Phenotype, Restriction Mapping, Sequence Deletion, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.